Categories: HealthcareNews

medmix Named One of Only Nine Swiss Companies for Climate Leadership

Baar, Switzerland–(Newsfile Corp. – May 19, 2025) –

medmix AG
Neuhofstrasse 20
CH-6430 Baar
communications@medmix.com
www.medmix.swiss

MEDIA RELEASE

DOWNLOAD MEDIA RELEASE

medmix named one of only nine Swiss companies for climate leadership

medmix has been recognized as one of only nine Swiss companies to achieve an “A” score in CDP’s annual climate change assessment, placing it in a select group of global environmental leaders. The company also received an “A-” score for water security, further distinguishing its environmental performance.

This exclusive recognition positions medmix alongside Switzerland’s most reputable corporations, including Novartis, ABB, Swisscom, and Georg Fischer. CDP is a globally renowned organization that evaluates companies’ environmental impacts and initiatives. Worldwide, only 2% of nearly 23,000 companies evaluated by CDP received an “A” score, highlighting the exclusive nature of this achievement.

This recognition reflects the consistent efforts we’ve made to integrate environmental principles across our businesses,” said René Willi, CEO of medmix. “We are pleased to see our approach to climate action being acknowledged at this level, underscoring our strategic commitment to environmental management and transparent reporting.

Looking ahead, medmix remains committed to advancing sustainable innovation across its product portfolio and operations. By continuously investing in sustainable technologies and collaborating with partners worldwide, the company aims to set new benchmarks for environmental responsibility in the industry.

-Ends-

About medmix

medmix is a global leader in high-precision delivery devices, with leading positions in healthcare, consumer and industrial end-markets. Our customers benefit from our dedication to innovation and technological advancement that has resulted in over 900 active patents. Our 14 production sites worldwide together with our highly motivated and experienced team of nearly 2’700 employees are at service of our customers with uncompromising quality, proximity and agility. medmix is headquartered in Baar, Switzerland. Our shares are traded on the SIX Swiss Exchange (SIX: MEDX). www.medmix.swiss

Inquiries:

Media Relations: communications@medmix.com

Investor Relations: investorrelations@medmix.com

This document may contain forward-looking statements including, but not limited to, projections of financial developments, market activity, or future performance of products and solutions containing risks and uncertainties. These forward-looking statements are subject to change based on known or unknown risks and various other factors that could cause actual results or performance to differ materially from the statements made herein.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/252568

Staff

Recent Posts

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

11 hours ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

14 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

14 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

14 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

14 hours ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

14 hours ago